Brief: Novocure Announces FDA Acceptance Of The Pma Application For Ttfields Therapy In Non-Small Cell Lung Cancer

NovoCure

18/01/2024 12:06

Jan 18 (Reuters) - Novocure Ltd  NVCR.O :
    * NOVOCURE ANNOUNCES FDA ACCEPTANCE OF THE PMA APPLICATION
FOR
TTFIELDS THERAPY IN NON-SMALL CELL LUNG CANCER
    * NOVOCURE LTD - PMA APPLICATION FOR LUNAR WAS SUBMITTED
WITH A
FILING DATE OF DECEMBER 15, 2023, AND IS NOW UNDER SUBSTANTIVE
REVIEW BY FDA
    * NOVOCURE LTD - NOVOCURE EXPECTS TO RECEIVE A REGULATORY
DECISION
FROM FDA IN SECOND HALF 2024

Source text for Eikon:  ID:nBw2Xw3R4a 
Further company coverage:  NVCR.O 

 ((Reuters.Briefs@thomsonreuters.com;))